Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire Harrison

Showing results (11-20 of 218) with videos related to

Pageof 22
Sort By:
Current Hematologic Malignancy Reports|October 5, 2013
Molecular classification of myeloproliferative neoplasms-pros and consMoosa Qureshi, Claire Harrison
Journal of Cellular and Molecular Medicine|December 31, 2013
Combination therapies in Myeloproliferative Neoplasms: why do we need them and how to identify potential winners?Donal McLornan, Claire Harrison
Hematology (Amsterdam, Netherlands)|March 12, 2014
MyelofibrosisClaire Harrison, Donal McLornan
Clinical Advances in Hematology & Oncology : H&O|March 19, 2008
Review: challenges in the management of thrombocytosis in young patientsSusan Robinson, Claire Harrison
Expert Opinion on Pharmacotherapy|June 21, 2023
Achievements and future outlook for JAK inhibitors in polycythaemia veraIpek Cakmak, Claire Harrison
Current Hematologic Malignancy Reports|February 20, 2016
How We Identify and Manage Patients with Inadequately Controlled Polycythemia VeraAndreas Reiter, Claire Harrison
Therapeutic Advances in Hematology|May 12, 2017
Experience with ruxolitinib in the treatment of polycythaemia veraSamah Alimam, Claire Harrison
Leukemia Research|November 9, 2010
Aspirin in low-risk essential thrombocythemia, not so simple after all?Claire Harrison, Tiziano Barbui
Expert Opinion on Pharmacotherapy|June 10, 2011
Management of myelofibrosis--where next?Moosa Qureshi, Claire Harrison
Expert Opinion on Pharmacotherapy|March 19, 2013
Polycythemia vera: can we do better?Farah Shariff, Claire Harrison
Pageof 22

Showing results (11-20 of 218) with videos related to

Sort By:
Pageof 22
Current Hematologic Malignancy Reports|October 5, 2013
Molecular classification of myeloproliferative neoplasms-pros and consMoosa Qureshi, Claire Harrison
Journal of Cellular and Molecular Medicine|December 31, 2013
Combination therapies in Myeloproliferative Neoplasms: why do we need them and how to identify potential winners?Donal McLornan, Claire Harrison
Hematology (Amsterdam, Netherlands)|March 12, 2014
MyelofibrosisClaire Harrison, Donal McLornan
Clinical Advances in Hematology & Oncology : H&O|March 19, 2008
Review: challenges in the management of thrombocytosis in young patientsSusan Robinson, Claire Harrison
Expert Opinion on Pharmacotherapy|June 21, 2023
Achievements and future outlook for JAK inhibitors in polycythaemia veraIpek Cakmak, Claire Harrison
Current Hematologic Malignancy Reports|February 20, 2016
How We Identify and Manage Patients with Inadequately Controlled Polycythemia VeraAndreas Reiter, Claire Harrison
Therapeutic Advances in Hematology|May 12, 2017
Experience with ruxolitinib in the treatment of polycythaemia veraSamah Alimam, Claire Harrison
Leukemia Research|November 9, 2010
Aspirin in low-risk essential thrombocythemia, not so simple after all?Claire Harrison, Tiziano Barbui
Expert Opinion on Pharmacotherapy|June 10, 2011
Management of myelofibrosis--where next?Moosa Qureshi, Claire Harrison
Expert Opinion on Pharmacotherapy|March 19, 2013
Polycythemia vera: can we do better?Farah Shariff, Claire Harrison
Pageof 22